Amylin Pharmaceuticals Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 237.3 | 422.2 | 66.6 |
| Net Receivables | 66.1 | 73.6 | 58.1 |
| Inventories | 115.8 | 100.2 | 59.3 |
| Other Current Assets | 616.9 | 740.3 | 722.8 |
| Total Current Assets | 1,036.1 | 1,336.3 | 906.8 |
| Net Fixed Assets | 636.9 | 390.3 | 146.8 |
| Other Noncurrent Assets | 39.6 | 47.6 | 6.8 |
| Total Assets | 1,712.6 | 1,774.2 | 1,060.4 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 39.5 | 37.5 | 36.8 |
| Short-Term Debt | 31.3 | -- | -- |
| Other Current Liabilities | 243.1 | 249.8 | 167.1 |
| Total Current Liabilities | 313.8 | 287.3 | 203.9 |
| Long-Term Debt | 868.8 | 931.0 | 213.8 |
| Other Noncurrent Liabilities | 179.2 | 3.1 | 7.4 |
| Total Liabilities | 1,361.8 | 1,221.4 | 425.1 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | 350.9 | 552.8 | 635.3 |
| Total Equity | 350.9 | 552.8 | 635.3 |
| Shares Outstanding (mil.) | 141.7 | 141.7 | 141.7 |
© 2009 Morningstar, Inc. Financial Data provided by
